Literature DB >> 12770781

Salvage pathways in glycosphingolipid metabolism.

G Tettamanti1, R Bassi, P Viani, L Riboni.   

Abstract

In this review, the focus is on the role of salvage pathways in glycosphingolipid, particularly, ganglioside metabolism. Ganglioside de novo biosynthesis, that begins with the formation of ceramide and continues with the sequential glycosylation steps producing the oligosaccharide moieties, is briefly outlined in its enzymological and cell-topological aspects. Neo-synthesized gangliosides are delivered to the plasma membrane, where their oligosaccharide chains protrude toward the cell exterior. The metabolic fate of gangliosides after internalization via endocytosis is then described, illustrating: (a) the direct recycling of gangliosides to the plasma membrane through vesicles gemmated from sorting endosomes; (b) the sorting through endosomal vesicles to the Golgi apparatus where additional glycosylations may take place; and (c) the channelling to the endosomal/lysosomal system, where complete degradation occurs with formation of the individual sugar (glucose, galactose, hexosamine, sialic acid) and lipid (ceramide, sphingosine, fatty acid) components of gangliosides. The in vivo and in vitro evidence concerning the metabolic recycling of these components is examined in detail. The notion arises that these salvage pathways, leading to the formation of gangliosides and other glycosphingolipids, sphingomyelin, glycoproteins and glycosaminoglycans, represent an important saving of energy in the cell economy and constitute a relevant event in overall ganglioside (or glycosphingolipid, in general) turnover, covering from 50% to 90% of it, depending on the cell line and stage of cell life. Sialic acid is the moiety most actively recycled for metabolic purposes, followed by sphingosine, hexosamine, galactose and fatty acid. Finally, the importance of salvage processes in controlling the active concentrations of ceramide and sphingosine, known to carry peculiar bioregulatory/signalling properties, is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770781     DOI: 10.1016/s0300-9084(03)00047-6

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  47 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 2.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

3.  Use of lissamine rhodamine ceramide trihexoside as a functional assay for alpha-galactosidase A in intact cells.

Authors:  Christine R Kaneski; Raphael Schiffmann; Roscoe O Brady; Gary J Murray
Journal:  J Lipid Res       Date:  2010-06-06       Impact factor: 5.922

Review 4.  Metabolic manipulation of glycosylation disorders in humans and animal models.

Authors:  Hudson H Freeze; Vandana Sharma
Journal:  Semin Cell Dev Biol       Date:  2010-04-02       Impact factor: 7.727

5.  Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1.

Authors:  E Andreas Larsson; Ulf Olsson; Colin D Whitmore; Rita Martins; Guido Tettamanti; Ronald L Schnaar; Norman J Dovichi; Monica M Palcic; Ole Hindsgaul
Journal:  Carbohydr Res       Date:  2006-10-07       Impact factor: 2.104

6.  Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C.

Authors:  Sharon Zhou; Cristin Davidson; Robert McGlynn; Gloria Stephney; Kostantin Dobrenis; Marie T Vanier; Steven U Walkley
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

Review 7.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

Review 8.  An introduction to sphingolipid metabolism and analysis by new technologies.

Authors:  Yanfeng Chen; Ying Liu; M Cameron Sullards; Alfred H Merrill
Journal:  Neuromolecular Med       Date:  2010-08-03       Impact factor: 3.843

9.  Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid.

Authors:  Kazuyuki Kitatani; Kely Sheldon; Viviana Anelli; Russell W Jenkins; Ying Sun; Gregory A Grabowski; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

10.  Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation.

Authors:  Kazuyuki Kitatani; Kely Sheldon; Vinodh Rajagopalan; Viviana Anelli; Russell W Jenkins; Ying Sun; Gregory A Grabowski; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.